placebo of cilostazol: Clinical Trials

3 trials of placebo of cilostazol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 2 Phase 4, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 42Unknown 2
Phase 31Completed 1

Follow placebo of cilostazol: new trials by email Literature Review of placebo of cilostazol trials Research Report on placebo of cilostazol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
cilostazol, Probucol, Aspirin - Brain Ischemia, Intracranial Hemorrhages
Phase 4UnknownAsan Medical Center8002009-06-012015-12-24
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Cilostazol, Probucol, Aspirin - Brain Ischemia, Intracranial Hemorrhages
Phase 4UnknownAsan Medical Center16002009-06-012015-12-24
Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.
cilostazol, placebo of cilostazol - Cerebral Infarction
Phase 3CompletedOtsuka Pharmaceutical Co., Ltd.10951992-04-012021-03-01

Conditions studied

Brain Ischemia (2)  ·  Intracranial Hemorrhages (2)  ·  Ischemic Stroke (2)  ·  Cerebral Infarction (1)

Sponsors

Asan Medical Center (2)  ·  Otsuka Pharmaceutical Co., Ltd. (1)

Countries

China (1)  ·  Japan (1)  ·  Philippines (1)  ·  South Korea (1)

Top investigators

Sun U Kwon, MD,PhD (1)  ·  Sun U. Kwon, MD, PhD (1)

Results publications

PMID 24957314, PMID 29778364, PMID 31856691, PMID 32027796, PMID 32664827, PMID 34155277, PMID 34779245, PMID 36700520